Edition:
United Kingdom

Anthera Pharmaceuticals Inc (ANTH.OQ)

ANTH.OQ on NASDAQ Stock Exchange Capital Market

2.40USD
23 Feb 2018
Change (% chg)

$0.04 (+1.69%)
Prev Close
$2.36
Open
$2.40
Day's High
$2.56
Day's Low
$2.17
Volume
706,281
Avg. Vol
158,515
52-wk High
$6.23
52-wk Low
$1.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.576
Jun '17 0.00 0.031
Mar '17 0.00 -2.028
FY 2016 Dec '16 0.00 -2.843
Sep '16 0.00 -4.853
Jun '16 0.00 -2.795
Mar '16 0.14 -2.342
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 8.93 26.80 0.00 12.67
Earnings (per share)
Quarter Ending Mar-18 4 -0.52 -0.37 -0.68 -3.60
Quarter Ending Jun-18 4 -0.50 -0.35 -0.68 -3.84
Year Ending Dec-18 5 -1.76 -0.78 -2.68 -9.24
LT Growth Rate (%) 1 10.00 10.00 10.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 2.64 0.90 0.89
Price to Sales (TTM) -- 110.72 5.77
Price to Book (MRQ) 4.14 13.56 5.41
Price to Tangible Book (MRQ) 3.95 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 29.16 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -100.00 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 101.11 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -8.63 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -10.66 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 1.40 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -6,110.54 -572.68 10.86
Operating Margin (TTM) -- -717.10 4.64
Operating Margin - 5 Yr. Avg. -6,157.96 -594.00 6.26
Pre-Tax Margin (TTM) -- -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -5,902.01 -597.35 6.60
Net Profit Margin (TTM) -- -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -5,902.01 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,602,130 855,673,508
Net Income/Employee (TTM) -1,222,939 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -178.48 -1.05 10.98
Return on Assets - 5 Yr. Avg. -121.35 -0.57 12.37
Return on Investment (TTM) -321.65 1.66 14.43
Return on Investment - 5 Yr. Avg. -194.59 2.23 16.18
Return on Equity (TTM) -434.34 2.58 16.13
Return on Equity - 5 Yr. Avg. -345.19 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -95.45 -- --
EPS (TTM) % -62.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Anthera Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 44.37%
# of Holders: 56
Total Shares Held: 6,144,575
3 Mo. Net Change: 3,361,268
# New Positions: 13
# Closed Positions: 10
# Increased Positions: 22
# Reduced Positions: 22
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.